LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Receivables (2025 - 2026)

Updated

LENZ Therapeutics (LENZ) posted Receivables of $442,000 for Q2 2026, up 28.9% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Receivables (2025 - 2026) Analysis & Trends

At the end of FY2025, LENZ Therapeutics' Receivables came in at $329,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 913,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 913,000.00
Jun 30, 2026 442,000.00
Mar 31, 2026 343,000.00
Dec 31, 2025 329,000.00
API Access

LENZ Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=LENZ&period=max&api_key=YOUR_API_KEY